1.product nam: erlotinib HCl 2.specification: 99%HPLC 3. CAS#: 183319-69-9 4. Iso 9001 5. high quality and reasonable price
CAS: 183319-69-9
Appearance Almost white to pale yellow powder
Melting Point 228C-230C
Loss on Drying NMT0.5%
Related Impurity by HPLC
Total impurity NMT1.5%
Single impurity NMT0.3%
Assay (HPLC) NLT99.0%
In-house standard
Packing:1kg/tin or according to customer request
U.S. FDA approval of its role standard in the treatment of advanced NSCLC invalid the second-tier or third-line treatment. The results showed that part of the programme combined with chemotherapy did not increase the response rate and survival of patients, for head and neck cancer, metastatic renal cell carcinoma, pancreatic cancer, breast cancer, Tarceva with chemotherapy or other targeted therapy drugs such as Avastin and used to good effect show
manufacture of Erlotinib hydrochloride 183319-69-9
